Abstract: Although highly effective, doxorubicin (DOX) use is limited by a dose-dependent cardiotoxicity. The purpose of this study was to determine whether resistance training (RT) would protect against DOX-induced cardiac dysfunction and determine whether any observed functional preservation is a result of reduced lipid peroxidation or a preservation of the cardiac myosin heavy chain (MHC) isoform distribution. Rats were resistance-trained or remained sedentary for 12 weeks, then treated with 12.5 mg/kg DOX or 0.9% saline. Five days after DOX exposure, cardiac function, lipid peroxidation, and MHC isoform expression were quantified. RT preserved cardiac function and attenuated the a-to b-MHC shift that occurs with DOX treatment. No significant differences in lipid peroxidation were observed between sedentary and RT animals treated with DOX. These data suggest that resistance-type exercise can provide protection against DOX-induced cardiac dysfunction, which may be a result of a preservation of the cardiac MHC isoform distribution.
INTRODUCTION
Anthracyclines such as doxorubicin (DOX) are highly effective antitumor agents that have widespread use in the treatment of both solid and hematological malignancies. 1 Although DOX is a potent chemotherapeutic agent, its utilization in routine cancer treatment regimens is complicated by a dose-dependent cardiotoxicity that can lead to cardiac dysrhythmias, contractile dysfunction and, possibly, congestive heart failure. 2 The implications of these cardiotoxic effects are far reaching, considering that the leading noncancer-related cause of mortality in cancer survivors is cardiovascular disease 3 and that cancer survivors are 8 times more likely to die from cardiovascular disease when compared with the general population. 4 Mechanistic actions of DOX responsible for cardiac toxicity include interference with deoxyribonucleic acid strand separation during replication, 5 induction of apoptosis, 6 and excess generation of reactive oxygen species. 7 These actions may cause significant shifts in myosin heavy chain (MHC) isoform distribution. DOX treatment has been shown to cause an upregulation in b-MHC with a corresponding downregulation in a-MHC. This a to b shift significantly slows cardiac force production and decreases cardiac contractility.
The role of regular exercise in the prevention of cancer and the attenuation of cancer treatment-related side effects has been the focus of much clinical research over the past 15 years. Although a substantial amount of research has concentrated on the effects of chronic endurance-type training, less attention has been directed at the effects of resistance training (RT) on DOX-induced cardiotoxicity. Cancer rehabilitation programs have begun to incorporate RT due to the fact that this type of training can result in significant improvements in muscular strength and aerobic capacity. [8] [9] [10] In addition, RT has been used as a rehabilitative therapy for heart failure, which may accompany DOX treatment, to counteract damaging peripheral side effects and enhance quality of life. 11 The purpose of this study was 3-fold: (1) to examine the effects of chronic RT before the administration of DOX on in vivo and ex vivo cardiac function in male Sprague Dawley rats, (2) to determine whether any cardioprotective effects are a result of a reduction in lipid peroxidation, and (3) to determine whether any cardioprotective effects are a result of a preservation of the cardiac MHC isoform distribution.
METHODS

Animals, Exercise Training, and DOX Administration
All protocols used for this study were approved by the University of Northern Colorado Institutional Animal Care and Use Committee and were in compliance with the Animal Welfare Act guidelines. Ten-week-old male Sprague Dawley rats (N = 48) were randomly assigned to sedentary (SED; n = 24) or RT (n = 24) groups and were housed in a temperaturecontrolled facility with a 12:12-hour light-dark cycle. Rats were provided standard rat chow and water ad libitum.
Animals that were randomly assigned to the RT group were placed in cages that allow for a progressive elevation of food and water, encouraging the animals to rise to a bipedal stance each time they eat and drink. Cage height (ie, cage lid) was raised to specified heights using specially designed plastic spacers that sat between the standard cage and the standard cage lid. Placement of the spacers between the cage and the lid raises food and water to the desired height. This RT model has been shown to increase hind limb muscle mass, tibial cortical bone, and peak twitch force, while decreasing muscular fatigue. 12, 13 On day one of the training protocol, cage height was raised from the standard 20.32 cm to a height of 28 cm. Cage height remained at 28 cm for 1 week. After the first week, height was raised by 2.5 cm. Thereafter, every 3rd day, cages were raised 2.5 cm until they reached the final height of 35.5 cm. This height was maintained for an additional 10 weeks for a total of 12 weeks of training. Food and body weight were recorded daily, and adequate water consumption was confirmed for the first 3 weeks of training to ensure that animals were able to reach both food and water. After the first 3 weeks of training, animals had their food measured and water monitored 3 days per week, and body weight was measured weekly.
At the completion of the 12-week training period, plastic spacers were removed so that food and water returned to the standard cage height. All animals remained in these standard cages for 24 hours before DOX administration. This was done to ensure that there were no effects of acute exercise on the observed dependent variables. After the 24-hour period, each animal was randomly assigned to 1 of 4 groups: SED + saline placebo (SAL) (n = 9), SED + DOX (n = 15), RT + SAL (n = 9), and RT + DOX (n = 15). SAL groups received a bolus intraperitoneal 0.9% saline injection, whereas DOX groups received a bolus intraperitoneal 12.5 mg/kg DOX injection.
Assessment of Cardiac Function In Vivo Cardiac Function
In vivo cardiac function was analyzed 5 days after DOX treatment using echocardiography. Animals were sedated with ketamine (40 mg/kg, intraperitoneal), and the anterior and left lateral thoracic regions were shaved. Transthoracic echocardiography was conducted on sedated rats using a General Electric Vivid 7 ultrasound with a 10-MHz intraoperative transducer (Tustin, CA). Measurements of septal wall thickness during systole and septal wall thickness during diastole, posterior wall thickness during systole and posterior wall thickness during diastole, left ventricular (LV) end systolic diameter and LV end diastolic diameter, and fractional shortening (FS) were acquired by M-mode tracings of the LV obtained in a short axis view. Flow images were obtained from an apical view using pulsed wave Doppler and used to measure maximal flow velocity through the mitral and aortic valves. Data for each variable were averaged from 3 consecutive cardiac cycles. All M-mode and Doppler measurements were made in accordance with guidelines established by the American Society of Echocardiography and were analyzed using UltraLinq ultrasound management system (New York, NY).
Ex Vivo Cardiac Function
Ex vivo cardiac function was analyzed after completing echocardiography using an isolated working heart model (ADInstruments, Colorado Springs, CO). Each animal was anesthetized using an intraperitoneal injection of heparinized (500 U) sodium pentobarbital (50 mg/kg). After an absent tail pinch reflex, the heart was excised and placed into ice cold Krebs-Henseleit buffer (in mM: 120 NaCl, 5.9 KCl, 2.5 CaCl 2 , 1.2 MgCl, 25 NaHCO 3 , 17 glucose, and 0.5 EDTA) aerated with 95% O 2 -5% CO 2 . Hearts were quickly cannulated by the ascending aorta and subjected to retrograde perfusion until all blood was cleared from the coronary vasculature. The pulmonary vein was then cannulated, and blood flow was redirected from the aorta to the left atrium to initiate the working heart model. Once stabilized, a microtip catheter pressure transducer (Millar Inc, Houston, TX) was placed into the LV through the apex for determination of LV developed pressure (LVDP), LV maximum rate of developed pressure (+dP/dt), and minimum rate of developed pressure (2dP/dt). Preload was set at 10 cm H 2 O and was maintained for all subsequent functional measurements. Afterload was progressively increased every 3 to 5 minutes during data collection from 85 cm H 2 O, to 100 cm H 2 O, and to 115 cm H 2 O. After data were collected at the 3 different afterloads, afterload was adjusted to 100 cm H 2 O, and hearts were paced at 240 beats per minute using electrodes attached to the cannula. Ventricular functional data were collected and analyzed using a PowerLab data acquisition system (ADInstruments). The LVs were then isolated, flash frozen in liquid nitrogen, and stored at 2808C until subsequent biochemical analyses.
Biochemical Analysis Lipid Peroxidation
A commercially available assay kit (Bioxytech MDA-586; OxisResearch, Foster City, CA) was used to measure malondialdehyde + 4-hydroxyalkenal (MDA + 4-HAE) as an indicator of cellular lipid peroxidation. Tissues were homogenized in a radioimmunoprecipitation buffer for the assay. A 200-mL aliquot of each sample was added to a microcentrifuge tube followed by 650 mL of N-methyl-2-phenylindole in acetonitrile and briefly vortexed. Next, 150 mL of methanesulfonic acid was added, vortexed, and incubated at 458C for 60 minutes. Samples were then centrifuged at 10,000g for 10 minutes. The resulting supernatant was transferred to a cuvette and absorbency measured using a spectrophotometer at a wavelength of 586 nm. The MDA + 4-HAE was determined from a standard curve. All samples were assayed in duplicate, and any samples varying more than 5% were reassessed.
MHC Analysis
MHC isoform distribution was analyzed using sodium dodecyl sulfate-polyacrylamide gel electrophoresis as described previously. 14 LV tissue was homogenized in 10 volumes of buffer (250 mmol/L sucrose, 100 mmol/L KCl, 5 mmol/L EDTA, and 20 mmol/L Tris-base, pH 6.8) and centrifuged at 1000g for 10 minutes. The pellet was washed (175 mmol/L KCl, 0.5% Triton X-100, 2 mmol/L EDTA and 20 mmol/L Tris-base, pH 6.8) and centrifuged twice, and the resulting pellet was resuspended (150 mmol/L KCl and 20 mmol/L Tris-base, pH 7.0). Total protein was determined using the Bradford method. 15 A total of 9.75 mg of protein from each sample was separated on an 8% polyacrylamide separating gel with a 4% polyacrylamide stacking gel and run at 100 V (Sure-Lock electrophoresis unit, Invitrogen Corporation, Carlsbad, CA) until tracking dye reached the bottom of the gel. Gels were stained with Coomassie blue, and a-and bisoforms were analyzed using densitometry.
Statistical Analyses
Data were analyzed and presented using GraphPad Prism statistical software. All data are expressed as mean 6 SD. A two-way analysis of variance (ANOVA) was used to determine significant difference due to the main effects (DOX and RT) and interaction. On observation of a significant difference, a Tukey post hoc pairwise comparison was conducted to evaluate all pairwise comparisons, which would identify differences between groups. For all statistical analyses, significance was set at a = 0.05.
RESULTS
General Observations
Six animals died during the course of this experiment, making the total mortality rate 20% for DOX-treated animals. The exercise intervention reduced mortality, with SED + DOX having a mortality rate of 27% (4/15), whereas the mortality rate for RT + DOX was 13% (2/15). Animal characteristics, summarized in Table 1 , show that both SAL groups continued to gain body weight in the 5 days after DOX treatment, although these gains were not significant. A 2-way ANOVA on final body weight revealed a drug effect, F(1,38) = 29.2, P , 0.0001, with body weight significantly lower in DOX-treated animals when compared with SAL-treated animals. Five days after injection, body weight decreased 14% for both DOX groups, with no statistically significant difference between DOX groups. A 2-way ANOVA on absolute heart mass revealed both a drug effect, F(1,38) = 6.757, P = 0.0132, and an activity effect, F(1,38) = 11.33, P = 0.0018. Absolute heart mass was significantly higher in the RT + SAL group compared with SED + DOX. Relative heart mass also showed a drug effect, F(1,38) = 5.448, P = 0.025, and an activity effect, F (1,38) = 18.87, P = 0.0001. Both RT groups had greater heart mass when compared with SED + SAL. Relative heart mass in RT + DOX was also significantly higher than in SED + DOX (Table 1 near here).
Echocardiography
Cardiac geometry and blood flow velocities were measured using echocardiography and the data are summarized in Table 2 . Five days after injection, a 2-way ANOVA on FS revealed a drug effect, F(1,27) = 12.65, P = 0.0014, an activity effect, F(1,27) = 9.76, P = 0.0044, and interaction, F (1,27) = 18.16, P = 0.0002. A post hoc analysis determined that both SAL groups and RT + DOX FS were significantly higher (P , 0.05) compared with SED + DOX. Echocardiography Doppler images were used to analyze maximal blood flow through the aortic valve (A-Vmax) and mitral valve (MVmax). A 2-way ANOVA on A-Vmax revealed a drug effect, F(1,38) = 79.25, P , 0.0001, an activity effect, F(1,38) = 15.03, P = 0.0004, and interaction, F(1,38) = 13.42, P = 0.0008. The M-Vmax also had a drug effect, F(1,37) = 82.44, P , 0.0001, an activity effect, F(1,37) = 7.002, P = 0.0119, and interaction, F(1,37) = 13.32, P = 0.008. Significant decreases in A-Vmax and M-Vmax occurred with both DOX groups when compared with both SAL groups. However, RT + DOX A-Vmax and M-Vmax was significantly faster (P , 0.05) when compared with SED + DOX.
Isolated Perfused Working Heart
After echocardiographic measurements, end systolic pressure (ESP), EDP, LVDP, +dP/dt, 2dP/dt, and heart rate were quantified using an isolated working heart apparatus. Afterload was set at 3 different heights (85, 100, and 115 cm H 2 O) during the analysis. No statistically significant differences in heart rate and EDP were observed between the 4 groups at any of the afterloads. Cardiac function at the 3 Figure 1 . At an afterload of 85 cm H 2 O, an interaction was observed for ESP, LVDP, and +dP/dt. A post hoc analysis revealed that both SAL groups and RT + DOX had significantly higher (P , 0.05) ESP, LVDP, and +dP/dt when compared with SED + DOX. Although ESP (34%) and LVDP (37%) were significantly higher in RT + DOX compared with SED + DOX, ESP and LVDP were significantly lower in RT + DOX when compared with both SAL groups.
At an afterload of 100 cm H 2 O, an interaction was observed for ESP, LVDP, and +dP/dt. Post hoc analysis revealed that both SAL groups and RT + DOX had significantly higher ESP, LVDP, and +dP/dt when compared with SED + DOX. The SED + DOX 2dP/dt was also significantly less when compared with SED + SAL. Similar to an afterload of 85 cm H 2 O, RT + DOX was significantly higher than SED + DOX in ESP (44%) and LVDP (46%); yet, these values were still significantly lower when compared with both SAL groups. +dP/dt for RT + DOX was also significantly lower when compared with SED + SAL.
At an afterload of 115 cm H 2 O, an interaction was observed for ESP, LVDP, and +dP/dt. A post hoc analysis revealed that both SAL groups and RT + DOX had significantly higher ESP, LVDP, +dP/dt, and 2dP/dt when compared with SED + DOX. Although RT + DOX was significantly higher than SED + DOX in ESP (44%), LVDP (46%), and +dP/dt (15%), these values were significantly lower when compared with both SAL groups.
After the collection of cardiac functional data in the unpaced condition, afterload was placed at 100 cm H 2 O and LV pressure was measured at a standardized pace of 240 beats/min (Fig. 2 ). An interaction was observed for ESP, LVDP, +dP/dt, and 2dP/dt at this afterload. Both SAL groups and RT + DOX had significantly higher ESP, LVDP, +dP/dt, and 2dP/dt when compared with SED + DOX. No significant differences were seen between RT + DOX and SAL groups for all variables.
As afterload increases, the normal physiological response is an increase in LV pressure. Although not significant, average increases approximating 5% were observed for both SAL groups in ESP, LVDP, and +dP/dt as the afterload increased from 85 cm H 2 O to 115 cm H 2 O. Both DOX groups showed little (,2%) to no change in ESP, LVDP, +dP/dt, and 2dP/dt as the afterload was increased from 85 cm H 2 O to 115 cm H 2 O.
Biochemical Analyses
All data from biochemical analyses are presented in Figures 3 and 4 . To provide an index of oxidative stressinduced damage in the myocardium, MDA + 4-HAE levels were analyzed. A 2-way ANOVA on MDA + 4-HAE levels revealed a drug effect, F(1,38) = 20.01, P , 0.0001. A post hoc analysis was performed to examine group differences. No significant differences were observed within DOX-treated or SAL-treated groups.
MHC isoform distribution was examined to determine whether an isoform shift played a protective role in DOX- 
DISCUSSION
With increased survival rates for cancer patients, it has become imperative to examine ways of attenuating cancer treatment-related side effects. DOX is one of the most effective chemotherapeutic agents ever developed; yet, its clinical utilization is often limited due to its dose-dependent cardiotoxicity. Extensive research has indicated that various types of exercise modalities can attenuate DOX-induced cardiotoxicity. [16] [17] [18] [19] Currently, cancer rehabilitation programs have begun to incorporate RT due to the fact that this type of training can result in significant improvements in muscular strength, aerobic capacity, and quality of life. [8] [9] [10] 20, 21 The primary purpose of this study was to determine whether chronic RT could attenuate the cardiac dysfunction induced by DOX treatment. In addition, the effect of DOX and exercise training on cardiac lipid peroxidation and relative MHC isoform distribution was examined to provide a potential explanation for any observed changes in cardiac function. Results indicate that DOX treatment caused cardiac dysfunction 5 days after its administration, chronic RT significantly attenuated this dysfunction, and the protective effects of this exercise modality were associated with a preservation of the MHC isoform distribution.
The DOX treatment regimen used in this study resulted in a significant impairment of cardiac function within 5 days of exposure, which is in agreement with previous investigations examining cardiac function at this time point. 22, 23 Cardiac dysfunction was manifested as a significant reduction in both mitral and aortic blood flow velocities as well as diminished systolic and diastolic function. There was a clear protective effect of the exercise intervention, evidenced by the fact that DOX-induced alterations in cardiac function were significantly attenuated in animals that were engaged in resistance exercise training.
DOX treatment in this investigation significantly reduced ESP, LVDP, and +dP/dt, which is in agreement with previous studies. 22, 24 The mechanisms responsible for DOXinduced LV systolic dysfunction are multifaceted and include cardiomyocyte apoptosis, 25 impaired Ca 2+ handling, 26, 27 and unfavorable MHC shifts. 22 This systolic dysfunction can result in decreases in stroke volume, ejection fraction, cardiac output, and systemic blood pressure, which in turn can lead to fatigue and a reduction in functional capacity. In this study, DOX-treated groups showed diminished diastolic function as well. Although significant differences were not observed in EDP between the 4 groups under baseline conditions, an increase in afterload did affect diastolic function in the form of diminished 2dP/dt for SED + DOX. The rate of myocardial relaxation was impaired in SED + DOX animals when afterload was increased from 100 cm H 2 O to 115 cm H 2 O, suggesting that diastolic dysfunction may be exacerbated at higher afterloads. Such an observation could have important implications for untrained cancer survivors who engage in infrequent exercise. Exposure to moderately elevated afterload-type activities such as high-intensity aerobic or resistance exercise may impair diastolic function during the activity. Several mechanisms could be involved in the impaired relaxation including diminished Ca 2+ uptake through sarcoendoplasmic reticulum ATPase 2 (SERCA2) as well as a decrease in SERCA2 mRNA expression, which have been observed in previous studies. 19, 22, [28] [29] [30] Although the mechanisms are not fully understood, others have suggested that SERCA2 impairment could be a result of DOXinduced oxidative stress, 31 which was in fact observed in the current study.
DOX-treated groups showed a significant increase in oxidative stress compared with SAL, which is supported by other studies. 23, 24, 32 The myocardium is highly aerobic, requiring a constant supply of ATP by oxidative phosphorylation. DOX administration can lead to excess generation of reactive oxygen species, mainly due to an increase in redox cycling at complex I in the electron transport chain. 33 An imbalance between antioxidant and pro-oxidant forces within and outside the cell can occur, which may lead to increases in oxidative stress. Increased oxidative stress can lead to a rise in intracellular Ca 2+ due to impaired ryanodine receptor and SERCA2 function. 34 Furthermore, this altered Ca 2+ homeostasis creates a cascade of events that can induce cellular apoptosis. 35 DOX-treated animals also showed a significant increase in the relative expression of b-MHC and a significant decrease in relative expression of a-MHC. DOX treatment has been shown to alter MHC isoform expression, 36 and cardiac function is extremely sensitive to even small changes in MHC expression. 37 Cardiac a-MHC is the primary isoform in rat hearts (.90%) and is associated with a greater contraction velocity and higher ATPase activity. 38 Others have shown that DOX treatment can alter MHC distribution causing a decrease in the expression of the a-MHC isoform and a corresponding increase in the expression of the b-MHC isoform. This a to b shift significantly decreases cardiac contractility and can have a profound impact on cardiac function. 39, 40 Despite the increased number of studies observing exercise-induced cardioprotection against DOX toxicity, no studies have determined whether RT before DOX treatment provides a cardioprotective effect. The RT model used in the current study protected against DOX-induced septal wall thinning, LV mass reduction, mitral and aortic blood flow decrements, and cardiac dysfunction. From available evidence, it seems that multiple mechanisms may be simultaneously involved with the protective effects of chronic exercise against DOX-induced cardiotoxicity including decreased oxidative stress 32, 41 and the preservation of MHC isoform distribution. 22 Expression of the a-MHC isoform has been shown to increase after various types of exercise. 42, 43 A possible mechanism involved in this increased expression of the a-MHC isoform may be an upregulation of myocardial thyroid hormone receptors. A study by Iemitsu et al (2004) detected significant increases in myocardial thyroid hormone receptor a1, which correlated with an increase in a-MHC isoform expression after 8 weeks of exercise. In the current study, RT + DOX animals showed significantly less change in MHC isoform distribution compared with SED + DOX, indicating a protective effect of the exercise intervention. This is supported by other studies showing that exercise attenuated MHC isoform shifts after DOX treatment 22 and suggests that the cardioprotection observed in this study may be due, at least in part, to the preservation of the MHC isoform distribution.
Resistance exercise has been shown to be cardioprotective in other models such as ischemia-reperfusion 44 and alcoholic cardiomyopathy. 45 Several mechanisms have been proposed to explain cardioprotection in these models including increased antioxidant potential, favorable inflammatory profiles, reduced autonomic nervous system dysfunction, enhanced coronary blood flow, and cardiomyocyte hypertrophy, all of which could potentially provide protection against DOX cardiotoxicity. Our laboratory recently elucidated a novel mechanism of cardioprotection against DOX-induced cardiotoxicity that involved the upregulation of multidrug resistance proteins, 46 which are responsible for the extrusion of DOX out of the cardiomyocyte thereby providing cardioprotection. It is possible that resistance exercise may favorably regulate MRPs in a similar fashion, but further studies must be conducted to answer these questions. The paucity of information describing the cardioprotective mechanisms of RT, particularly in the context of cancer and cancer treatments, warrants further studies in this area.
CONCLUSION
This is the first study to provide evidence suggesting that resistance-type exercise may preserve cardiac function and prevent deleterious MHC shifts after DOX treatment. DOX exposure resulted in impaired cardiac function, increased lipid peroxidation, and unfavorable shifts in the cardiac MHC isoform distribution. However, 12 weeks of RT resulted in a preservation of cardiac function, which was associated with less oxidative stress and a more favorable cardiac MHC isoform distribution. These findings suggest that chronic resistance exercise may be a beneficial counter measure to DOX-induced cardiotoxicity and support the notion that incorporating resistance exercise into a rehabilitation program may improve functional capacity and quality of life for cancer survivors.
